Doximity Acquires Pathway, a Leader in AI Clinical Reference
Physicians make up half of Pathway’s team. Over the past seven years, they’ve assembled one of the largest structured datasets in medicine—purpose-built for AI—spanning nearly every guideline, drug, and landmark trial across all major specialties. Pathway’s model outperforms others in clinical accuracy, recently scoring a record
“We’re thrilled to welcome the Pathway team to Doximity,” said Jeff Tangney, co-founder and CEO of Doximity. “They’ve painstakingly built one of the best datasets in medicine, and it’s going to take our clinical reference capabilities to an entirely new level.”
“There’s a growing need for clinical tools that combine trusted evidence with the speed and adaptability of AI,” said Jon Hershon, CEO of Pathway. “Hundreds of thousands of users have registered for Pathway, and thousands pay
The transaction closed on July 29, 2025 for cash consideration of
About Doximity
Founded in 2010, Doximity is the leading digital platform for
About Pathway
Pathway helps clinicians deliver better, faster, more informed care by providing instant and evidence-based answers to medical questions. The AI-powered platform has hundreds of thousands of registered users, with a strong presence in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20250807262957/en/
For investors:
Perry Gold
ir@doximity.com
For media:
Amanda Cox
pr@doximity.com
Source: Doximity